EA202191829A1 - Препараты для предотвращения заболеваний, приобретенных через ротовую полость и глотку - Google Patents

Препараты для предотвращения заболеваний, приобретенных через ротовую полость и глотку

Info

Publication number
EA202191829A1
EA202191829A1 EA202191829A EA202191829A EA202191829A1 EA 202191829 A1 EA202191829 A1 EA 202191829A1 EA 202191829 A EA202191829 A EA 202191829A EA 202191829 A EA202191829 A EA 202191829A EA 202191829 A1 EA202191829 A1 EA 202191829A1
Authority
EA
Eurasian Patent Office
Prior art keywords
ingredients
prevent
toothpastes
oral
extract
Prior art date
Application number
EA202191829A
Other languages
English (en)
Inventor
Джозеф Г. Монтес
Джеймс Интрейтер
Original Assignee
Интрамонт Текнолоджис, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/353,802 external-priority patent/US11517523B2/en
Application filed by Интрамонт Текнолоджис, Инк. filed Critical Интрамонт Текнолоджис, Инк.
Publication of EA202191829A1 publication Critical patent/EA202191829A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/16Fluorine compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Настоящее изобретение включает зубную пасту или другой продукт для перорального введения, который следует использовать по меньшей мере один раз в день для предотвращения или подавления заражения тканей полости рта или глотки рядом инфекций, в том числе, в частности, "обычной" простудой. Предложенные композиции содержат комбинацию ингредиентов, которая не встречается в других зубных пастах или других продуктах для перорального применения, при этом указанные ингредиенты действуют вместе и синергетически препятствуют заражению рядом патогенов. Такие зубные пасты содержат обычные ингредиенты для чистки зубов, которые, как известно, предотвращают зубной кариес, а также ингредиенты, уменьшающие галитоз (т.е. неприятный запах изо рта) и предотвращающие гингивит. Кроме того, предложенные зубные пасты включают один или более из следующих компонентов: 1) GALALCOOL (Галалкул) в виде отдельного соединения, а не в виде компонента экстракта; 2) протопорфирин IX цинка; и 3) один или более другой бесцветный или слабоокрашенный танин(ы), каждый в виде отдельного соединения, а не в виде компонента экстракта.
EA202191829A 2019-03-14 2020-03-16 Препараты для предотвращения заболеваний, приобретенных через ротовую полость и глотку EA202191829A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/353,802 US11517523B2 (en) 2017-09-12 2019-03-14 Oral-surface administered preparation for the prevention of illnesses acquired via the oral cavity and the pharynx
PCT/US2020/022903 WO2020186258A1 (en) 2019-03-14 2020-03-16 Preparations for the prevention of illnesses acquired via the oral cavity and pharynx

Publications (1)

Publication Number Publication Date
EA202191829A1 true EA202191829A1 (ru) 2021-12-21

Family

ID=72426456

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191829A EA202191829A1 (ru) 2019-03-14 2020-03-16 Препараты для предотвращения заболеваний, приобретенных через ротовую полость и глотку

Country Status (12)

Country Link
EP (1) EP3937879A4 (ru)
JP (1) JP2022524486A (ru)
CN (1) CN113453664A (ru)
AU (1) AU2020235666A1 (ru)
BR (1) BR112021016277A2 (ru)
CA (1) CA3128127A1 (ru)
CL (1) CL2021002202A1 (ru)
DO (1) DOP2021000171A (ru)
EA (1) EA202191829A1 (ru)
IL (1) IL286256A (ru)
MX (1) MX2021009928A (ru)
WO (1) WO2020186258A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023520607A (ja) * 2020-03-19 2023-05-17 レニバス・セラピューティクス・インコーポレイテッド コロナウイルス感染の治療のための方法
CN111759851B (zh) * 2020-08-17 2021-01-26 广东盛普生命科技有限公司 单宁酸在制备抗冠状病毒的药物方面的应用
CN112402450A (zh) * 2020-11-26 2021-02-26 江苏泰德医药有限公司 一种防治新冠病毒的产品及制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB189324273A (en) * 1893-12-16 1895-02-02 Otto Christian Hagemann Improvements in the Extraction and Purification of Tannin.
JPS53148542A (en) * 1977-05-27 1978-12-25 Reiichi Yamaga Pharmaceutical composition densistry
US5409905A (en) * 1981-01-05 1995-04-25 Eby, Iii; George A. Cure for commond cold
JP3570482B2 (ja) * 1997-12-02 2004-09-29 ライオン株式会社 歯磨組成物及び苦味抑制方法
US20020009478A1 (en) * 1998-08-24 2002-01-24 Douglas Joseph Dobrozsi Oral liquid mucoadhesive compositions
WO2004098566A2 (en) * 2003-04-30 2004-11-18 Zicam, Llc Chewable lozenge cold remedy composition and method for making same
US20060141072A1 (en) * 2004-12-29 2006-06-29 Arvanitidou Evangelia S Oxidation resistant dentifrice compositions
US8900557B2 (en) * 2010-12-30 2014-12-02 Jr Chem, Llc Dental cleaning composition
US20140377373A1 (en) * 2011-11-10 2014-12-25 Lankenau Institute For Medical Research Compositions and Methods for the Prevention of Microbial Infections
CN106061487A (zh) * 2014-02-03 2016-10-26 里兰斯坦福初级大学理事会 用于微粒递送锌原卟啉的制剂
WO2015178791A1 (ru) * 2014-05-23 2015-11-26 Артур Викторович МАРТЫНОВ Косметологическая и фармацевтическая композиция
WO2016067283A1 (en) * 2014-10-30 2016-05-06 Rice Howard Virucidal compositions comprising tannins for nasal and pulmonary administration
ITUB20153821A1 (it) * 2015-09-23 2017-03-23 Agrocube S A Composizione biostimolante a base di tannini e/o loro derivati, pr il trattamento di vegetali coltivati e/o di loro parti
US20190076335A1 (en) * 2017-09-12 2019-03-14 IntraMont Technologies, Inc. Oral-surface administered preparation for the prevention of illnesses acquired via the oral cavity and the pharynx
US11517523B2 (en) * 2017-09-12 2022-12-06 IntraMont Technologies, Inc. Oral-surface administered preparation for the prevention of illnesses acquired via the oral cavity and the pharynx
CN108220031A (zh) * 2018-02-26 2018-06-29 酒泉市祁连天脉养生果酒有限公司 高品质陈酿型黑枸杞葡萄酒及其制备方法

Also Published As

Publication number Publication date
EP3937879A1 (en) 2022-01-19
IL286256A (en) 2021-10-31
BR112021016277A2 (pt) 2021-10-13
JP2022524486A (ja) 2022-05-06
MX2021009928A (es) 2021-09-21
CA3128127A1 (en) 2020-09-17
EP3937879A4 (en) 2022-12-14
WO2020186258A1 (en) 2020-09-17
CN113453664A (zh) 2021-09-28
AU2020235666A1 (en) 2021-08-26
DOP2021000171A (es) 2021-10-15
CL2021002202A1 (es) 2022-06-10

Similar Documents

Publication Publication Date Title
EA202191829A1 (ru) Препараты для предотвращения заболеваний, приобретенных через ротовую полость и глотку
Balagopal et al. Chlorhexidine: the gold standard antiplaque agent
EP0049830B1 (en) Mouthwash compositions comprising hexetidine and zinc salts for the synergistic inhibition of dental plaque
RU2017130866A (ru) Композиции для ухода за полостью рта и способы их применения
RU2017128411A (ru) Композиции для ухода за полостью рта и способы их применения
DePaola et al. Safety and efficacy of antimicrobial mouthrinses in clinical practice
RU2012135284A (ru) Продукт для ухода за полостью рта и способы его применения
JP2012522752A (ja) 4−イソプロピル−3−メチルフェノールおよび亜鉛イオンを含む抗菌組成物
Ennibi et al. Chlorhexidine alcohol base mouthrinse versus chlorhexidine formaldehyde base mouthrinse efficacy on plaque control: double blind, randomized clinical trials
JP2018515420A (ja) 改善されたマウスウォッシュ製剤
Ernst et al. Clinical study on the effectiveness and side effects of hexetidine and chlorhexidine mouthrinses versus a negative control
Tangade et al. Anti-gingivitis effects of Acacia arabica-containing toothpaste
JP5310556B2 (ja) 口腔用組成物及び口腔用組成物の収斂性向上方法
US6589513B2 (en) Oral hygiene formulation and method of use
PH12020500499A1 (en) Oral-surface administered preparation for the prevention of illnesses acquired via the oral cavity and the pharynx
Al-Mahmood et al. Comparative evaluation of the effectiveness of 40% miswak mouthwash and 0.12% chlorhexidine mouthwash in treating gingivitis: a blinded, randomised clinical trial
CA2854893A1 (en) Alcohol-free mouthwash
Alshehri et al. Comparison of an essential-oil-based oral rinse and chlorhexidine as adjuncts to scaling and root planing in the treatment of periodontal inflammation
CN105726441A (zh) 一种保健牙釉质、改善牙龈的牙膏
Jameel et al. Is synthetic mouthwash the final choice to treat oral malodour
US20230364001A1 (en) Tooth anti-staining composition, kit and method of using the same
Alshehri Effect of Silver diamine fluoride on the treatment of gingivitis in geriatric patients
RU2272662C1 (ru) Композиция по уходу за полостью рта
RU2108775C1 (ru) Лечебно-профилактическая композиция для обработки зубов
RU2235534C1 (ru) Средство для полоскания рта